HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.

AbstractBACKGROUND:
The "complex of myxomas, spotty skin pigmentation, and endocrine overactivity," or "Carney complex" (CNC), is caused by inactivating mutations of the regulatory subunit type 1A of the cAMP-dependent protein kinase (PRKAR1A) gene and as yet unknown defect(s) in other gene(s). Delineation of a genotype-phenotype correlation for CNC patients is essential for understanding PRKAR1A function and providing counseling and preventive care.
METHODS:
A transatlantic consortium studied the molecular genotype and clinical phenotype of 353 patients (221 females and 132 males, age 34 +/- 19 yr) who carried a germline PRKAR1A mutation or were diagnosed with CNC and/or primary pigmented nodular adrenocortical disease.
RESULTS:
A total of 258 patients (73%) carried 80 different PRKAR1A mutations; 114 (62%) of the index cases had a PRKAR1A mutation. Most PRKAR1A mutations (82%) led to lack of detectable mutant protein (nonexpressed mutations) because of nonsense mRNA mediated decay. Patients with a PRKAR1A mutation were more likely to have pigmented skin lesions, myxomas, and thyroid and gonadal tumors; they also presented earlier with these tumors. Primary pigmented nodular adrenocortical disease occurred earlier, was more frequent in females, and was the only manifestation of CNC with a gender predilection. Mutations located in exons were more often associated with acromegaly, myxomas, lentigines, and schwannomas, whereas the frequent c.491-492delTG mutation was commonly associated with lentigines, cardiac myxomas, and thyroid tumors. Overall, nonexpressed PRKAR1A mutations were associated with less severe disease.
CONCLUSION:
CNC is genetically and clinically heterogeneous. Certain tumors are more frequent, with specific mutations providing some genotype-phenotype correlation for PRKAR1A mutations.
AuthorsJérôme Bertherat, Anélia Horvath, Lionel Groussin, Sophie Grabar, Sosipatros Boikos, Laure Cazabat, Rosella Libe, Fernande René-Corail, Sotirios Stergiopoulos, Isabelle Bourdeau, Thalia Bei, Eric Clauser, Alain Calender, Lawrence S Kirschner, Xavier Bertagna, J Aidan Carney, Constantine A Stratakis
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 94 Issue 6 Pg. 2085-91 (Jun 2009) ISSN: 1945-7197 [Electronic] United States
PMID19293268 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclic AMP-Dependent Protein Kinase RIalpha Subunit
Topics
  • Adolescent
  • Adrenal Cortex Diseases (complications, genetics)
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Cyclic AMP-Dependent Protein Kinase RIalpha Subunit (genetics)
  • DNA Mutational Analysis
  • Female
  • Genotype
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Mutation (physiology)
  • Myxoma (complications, genetics)
  • Phenotype
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: